Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Myriad Genetics Expands Partnership with Illumina to Enhance Genomic Profiling for Cancer Detection

Myriad Genetics updates its agreement with Illumina, integrating GIS for broader cancer diagnostics using TruSightâ„¢ Oncology 500 v2.Quiver AI SummaryMyriad Genetics has announced an update to its agreement...

MYGN : 15.12 (-1.18%)
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

MYGN : 15.12 (-1.18%)
Myriad Genetics Launches Prequel® Prenatal Screen Available as Early as Eight Weeks into Pregnancy

Myriad Genetics' Prequel® Prenatal Screen now offers genetic testing at eight weeks of pregnancy, enhancing early decision-making for expectant parents.Quiver AI SummaryMyriad Genetics, Inc. has announced...

MYGN : 15.12 (-1.18%)
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

MYGN : 15.12 (-1.18%)
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

MYGN : 15.12 (-1.18%)
Myriad: Q3 Earnings Snapshot

Myriad: Q3 Earnings Snapshot

MYGN : 15.12 (-1.18%)
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

MYGN : 15.12 (-1.18%)
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

MYGN : 15.12 (-1.18%)
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

MYGN : 15.12 (-1.18%)
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

MYGN : 15.12 (-1.18%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar